{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid2oigyrkyffu46kgjbobo7h2cm3ye5xkaeium2wifuwcongfkiie",
    "uri": "at://did:plc:nzm6xlhdk3myu4xft63gxqp4/app.bsky.feed.post/3mpjmm7b43lp2"
  },
  "path": "/markets/buzz-on-experimental-drug-for-bowel-disease-sets-this-biotech-stock-soaring-40-11708749",
  "publishedAt": "2026-06-30T17:23:49.000Z",
  "site": "https://www.ndtvprofit.com",
  "tags": [
    "Markets"
  ],
  "textContent": "Abivax stock rebounds as new trial data eases safety concerns over ulcerative colitis drug",
  "title": "Buzz On Experimental Drug For Bowel Disease Sets This Biotech Stock Soaring 40%"
}